Arecor Therapeutics appoints Simon Ormiston to its Board as Non-Executive Director

– UK, Cambridge –  Arecor Therapeutics plc (LON: AREC), the biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases, announced the appointment of Simon Ormiston to its Board as a Non-Executive Director and the new Chair of the Audit & Risk Committee, with immediate effect.…

Talent4Boards
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.